Psychosis Archives - Page 2 of 4

Childhood and adolescent psychotic experiences and risk of mental disorder: a systematic review and meta-analysis

Jul 24, 2019

Colm Healy (a1), Ross Brannigan (a1) (a2), Niamh Dooley (a1), Helen Coughlan (a1) ... Psychological Medicine. Volume 49, Issue 10 July 2019 , pp. 1589-1599. DOI: https://doi.org/10.1017/S0033291719000485 Psychotic experiences are common during ch...

CYP2D6 testing to guide risperidone and aripiprazole therapy

May 17, 2019

Chad A Bousman. Lancet Psychiatry. Published:April 15, 2019DOI:https://doi.org/10.1016/S2215-0366(19)30138-5 The CYP2D6 gene encodes cytochrome P450 2D6, an enzyme that plays a crucial role in the metabolism of all tricyclic antidepressants,...

Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials

May 17, 2019

Cho, M., Lee, T. Y., Kwak, Y. B., Yoon, Y. B., Kim, M., & Kwon, J. S. (2019). Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867419835028 This systematic review provides evidence that adjunctive use of ant...

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

May 17, 2019

Di Forti M, Quattrone D, et al. Lancet Psychiatry. Open Access Published:March 19, 2019DOI:https://doi.org/10.1016/S2215-0366(19)30048-3 Although some argue that legalising cannabis is a good idea, this study demonstrates that countries in w...

Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis

Nov 15, 2018

Siskind D, Hahn M, Correll CU, et al. Diabetes Obes Metab. 2018 Sep 5. doi: 10.1111/dom.13522. (Review) PMID: 30187620 This systematic review of 3 studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs) found that they are effective an...

Effect of cannabidiol on medial temporal, midbrain, and striatal dysfunction in people at clinical high risk of psychosis: a randomized clinical trial

Nov 15, 2018

Bhattacharyya S, Wilson R, Appiah-Kusi E, et al. JAMA Psychiatry. 2018;75(11):1107–1117. doi:10.1001/jamapsychiatry.2018.2309 This fMRI study of 33 individuals at high risk of developing psychosis showed that a single dose of cannabidiol normal...

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

Sep 12, 2018

Kahn RS, Winter van Rossum I, et al. Lancet. Published online:August 13, 2018 DOI:https://doi.org/10.1016/S2215-0366(18)30252-9 This three-phase study conducted in 27 European centres investigated the value of reducing a currently used three-step ...

18 $Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis$

Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis

Jun 10, 2018

Siskind DJ, Lee M, Ravindran A, et al. Australian & New Zealand Journal of Psychiatry. Published online May 6 2018. https://doi.org/10.1177/0004867418772351 This systematic review of 46 studies of 25 interventions found that the best evidenc...

Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis A Systematic Review, Meta-analysis, and Meta-regression

May 27, 2018

Correll CU, Galling B, Pawar A, et al. JAMA Psychiatry. Published online May 02, 2018. doi:10.1001/jamapsychiatry.2018.0623 Despite the initial enthusiasm for early intervention services, there has been more recent criticism regarding the value o...

Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial

Apr 18, 2018

Hui CLM, Honer W, Lee E, et al. The Lancet Psychiatry , Published online April 2018. This paper describes a ten-year follow-up study of a randomised controlled trial from seven centres in Hong Kong in which 178 patients with first-episode psychosi...

Archive

Archives for: Psychosis

Childhood and adolescent psychotic experiences and risk of mental disorder: a systematic review and meta-analysis

CYP2D6 testing to guide risperidone and aripiprazole therapy

Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis

Effect of cannabidiol on medial temporal, midbrain, and striatal dysfunction in people at clinical high risk of psychosis: a randomized clinical trial

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis

Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis A Systematic Review, Meta-analysis, and Meta-regression

Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial

Find us on